Advertisement

Topics

AstraZeneca reports post-progression data for lung cancer drug Tagrisso

10:40 EDT 16 Apr 2018 | Net Resources International

Anglo-Swedish biopharma AstraZeneca has reported post-progression outcome data from its Phase III FLAURA trial, investigating the efficacy and safety of...
Read More...

The post AstraZeneca reports post-progression data for lung cancer drug Tagrisso appeared first on Drug Development Technology.

Original Article: AstraZeneca reports post-progression data for lung cancer drug Tagrisso

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca reports post-progression data for lung cancer drug Tagrisso"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...